Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT01118962
- Locations
- 🇺🇸
609, Bethesda, Maryland, United States
🇺🇸601, Nashville, Tennessee, United States
🇺🇸605, Lexington, Kentucky, United States
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
- First Posted Date
- 2009-08-19
- Last Posted Date
- 2015-08-06
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00961441
An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2022-01-18
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 366
- Registration Number
- NCT00938912
- Locations
- 🇺🇸
Sp848 016, Pittsburgh, Pennsylvania, United States
🇺🇸Sp848 068, Cincinnati, Ohio, United States
🇺🇸Sp848 061, Las Vegas, Nevada, United States
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 3072
- Registration Number
- NCT00844285
- Locations
- 🇺🇸
C87075 517, Great Neck, New York, United States
🇺🇸C87075 413, Great Neck, New York, United States
🇺🇸C87075 237, Houston, Texas, United States
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT00655486
Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00655551
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
- First Posted Date
- 2007-08-29
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 308
- Registration Number
- NCT00522275
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures
- First Posted Date
- 2007-08-27
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- UCB BIOSCIENCES, Inc.
- Target Recruit Count
- 426
- Registration Number
- NCT00520741
- Locations
- 🇺🇸
61, Columbus, Ohio, United States
🇺🇸32, Philadelphia, Pennsylvania, United States
🇺🇸79, Atlanta, Georgia, United States
© Copyright 2024. All Rights Reserved by MedPath